Highland Global Allocation Fund is a US-based company operating in industry. The company is headquartered in Dallas, Texas. The company went IPO on 2019-02-19. Highland Global Allocation Fund (the Fund) is a diversified, closed-end management investment company. The Fund seeks to achieve its investment objectives by investing in a portfolio of United States and foreign equity, debt and money market securities. The Fund intends to invest at least 50% of its net assets in equity securities and at least 40% of its net assets in securities of non-United States issuers. The Fund may also invest in debt securities of any kind, including debt securities of varying maturities, debt securities paying a fixed or fluctuating rate of interest, inflation-indexed bonds, structured notes, loan assignments, loan participations, asset-backed securities, debt securities convertible into equity securities, and securities issued or guaranteed by the United States. The Fund's investment adviser is NexPoint Asset Management, L.P.
最新の財務諸表(Form-10K)によると、Pro Medicus Ltdの総資産は$0で、純損失は$0です。
HGLBの主要な財務比率は何ですか?
Pro Medicus Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Highland Global Allocation Fundの収益はセグメントまたは地域別にどのように分けられていますか?
Pro Medicus Ltd の最大収益セグメントは Radiology Information Systems (RIS) で、最新の利益発表における収益は 15,886,000 です。地域別に見ると、Australia が Pro Medicus Ltd の主要市場であり、収益は 17,700,000 です。